Artlabeling Activity Anatomy and Histological Organization of the Spleen
Introduction
Splenomegaly is non regarded equally a affliction of its own, but rather as a potential symptom associated with different disorders. In healthy individuals a spleen is ordinarily not palpable in most cases. A patient exhibiting splenomegaly may therefore nowadays with a number of clinical signs and laboratory or imaging findings that are ordinarily associated with distinct diseases ranging from self-limiting benign to infectious disorders or even malignancies. Thus, the finding of an enlarged spleen in a patient should be investigated properly to ascertain the etiology which may correspond a diagnostic challenge in some cases.
Establishing a practical clinical definition of splenomegaly is not picayune and also there is no generally accepted grading of splenomegaly. Length or weight of the organ are typically used to characterize its size. In adults, spleens normally measure below 14 cm in the longest craniocaudal bore, moderately enlarged spleens are 14–twenty cm long, and severely enlarged spleens exceed 20 cm (1). Concerning weight, a spleen weighing 500–i,000 g is categorized as splenomegalic and more one,000 chiliad are classified as "massive". In adults, the clinical finding of a palpable spleen is generally considered as splenomegaly, but if imaging procedure are practical upwardly to 16% of these organs are described to be of normal size (2). In children, any categorization must consider the age-dependent increase in size of the organ (three) (Effigy i).
Figure ane. Range of spleen size (longitudinal diameter) assessed by ultrasound examination according to age in Caucasians (For details see Table ii, normal range denotes the ii.fifth to 97.5th percentiles). Figure modified from (three).
This article aims to summarize the bones anatomy, the physiological background and the disorders causing splenomegaly. Information technology may guide the pediatrician on the way to adopt a systematic arroyo to identify a serious disease including those challenging patients presenting with isolated splenomegaly.
Anatomy and Physiology
The spleen is positioned in the upper left intestinal crenel betwixt the gastric fundus and the diaphragm, side by side to the costal margin betwixt the 9th and 11th ribs (iv). Ligaments fix the spleen in its normal position and absent-minded or abnormal laxity of these suspensory may cause a so-called wandering spleen. This rare clinical entity predominantly affects children younger than 10 years with an incidence rate of 0.2% (v). If the spleen is attached merely to a unmarried elongated vascular pedicle, this situation predisposes to torsion and serious complications and is chosen a wandering spleen.
The spleen represents the biggest organ of the lymphatic system with a spongy reddish-purple appearance due to its dumbo vascularization. The surface is fabricated by a compact fibroelastic tissue sheathing containing some smooth muscle fibers. The sheathing protects the organ and contributes to its expansion and contraction. It is subdivided into many smaller internal sections termed lobules (Effigy 2A). The parenchyma of the spleen is called pulp and contains two different types of tissues, termed white lurid (25% of the full splenic book) and ruddy lurid, each executing distinct physiological functions.
Figure ii. (A) Organization of macroscopic visible structures in the man spleen and schematic presentation of blood vessels and white and cherry-red pulp. Original photo from (6). (B) Schematic diagram of the microstructure of the spleen. For details see text. (C) Schematic drawing of a venous sinus located in the red pulp cords. Claret cells from the cords are simply collected into the venous sinuses if they manage to laissez passer the slits betwixt the endothelial cells (shown by red arrows). Figure modified from (7).
The white lurid -which is embedded in the red pulp- is primarily lymphatic and participates in the office of the immune arrangement. The central arteries (intermediate-sized arterial vessels supplying each lobule) are surrounded past T- and B-lymphocytes forming aggregates, the periarteriolar lymphatic sheaths (T-cell dominant) and the follicles (B-cell dominant lymphatic nodules (Figures 2A,B). In the marginal zone separating white and ruby-red pulp, which is rich in macrophages and dendritic cells, pathogens, e.g., microorganisms and particulate antigens from the claret stream are filtered out and presented to the lymphocytes residing in the white pulp (4). Lymphocytes and antigen-presenting cells interact to built-upward the humoral immune response via B-lymphocyte proliferation, and the innate immune response via cytokine signaling and phagocytosis (vii). The spleen exerts a major role in the synthesis of immunoglobulin 1000, of properdin, which is an essential component of the alternate pathway of complement activation, and of the immunostimulatory tetrapeptide tuftsin (8).
The major proportion of the splenic volume (75%) is formed by the carmine pulp composed of a reticular connective tissue which incorporates splenic venous sinuses, cords, and perisinusoidal macrophages. The microstructure of the spleen is shown in a schematic diagram in Figure 2B. The initial segments of sinusoid capillaries are surrounded by special multicellular structures termed capillary sheaths. In humans these specialized vascular capillaries are located distal to branching points of terminal arterioles in the red lurid. Besides accumulations of B-lymphocytes they comprise specialized cuboidal inner sheath cells surrounded by macrophages (9, 10). Stromal sheath cells possibly play a office in enriching macrophages and B-lymphocytes at a location where antigens get-go enter the spleen, but their detailed specific part is a subject of ongoing enquiry (11).
Approximately 5% of the cardiac output volume passes the spleen each infinitesimal (12). A 90% proportion of this blood volume travels to the crimson pulp (xiii). The human splenic microcirculation is both open and closed, with the open part forming the major proportion.
When the blood has left the open up ends of the splenic red pulp arterioles (Figure 2B), it feeds an open microcirculation within the reticular connective tissue of the red lurid without endothelial barriers. The pocket-sized function of the airtight microcirculation is formed by merely a few connections between the ruddy pulp capillary network and the ruddy lurid venules (11).
From the open up microcirculation in the red pulp the blood is re-collected for venous drainage. At this point for entering into the splenic venous capillaries, the claret menses has to tedious downwardly to let cells to clasp through the slits between the endothelial cells. Red cells with membrane alterations resulting in deformability impairment due to inherited membrane defects (spherocytosis, elliptocytosis) or hemoglobinopathies (sickle cell illness, thalassemia) and, in salubrious individuals, senescent erythrocytes cannot pass through the slits (Figure 2C). Thus, this is the identify where the degradation of quondam erythrocytes happens due to phagocytosis past red pulp macrophages. The venous sinuses are formed by a parallel lining of endothelial cells which are continued past stress fibers to annular fibers (Figure 2C). Wrinkle of the stress fibers will result in formation of slits between the endothelial cells. The width of theses slits regulates the passage of claret cells and blood plasma from the blood-red pulp cords into the sinuses and further into the venous system (7).
Epidemiology of Splenomegaly
Splenomegaly is a rare finding. In the USA the estimated prevalence is in the range of ~ii% of the total population (xiv). The incidence of splenomegaly is strongly dependent on the geographical location reflecting the etiology equally causes may vary with diseases prevalent in a given expanse (15). In Asia and Africa, tropical splenomegaly due to malaria, sickle cell disease or schistosomiasis is very common (16). Concerning the underlying causes of splenomegaly differences betwixt developing and developed countries are quite obvious (17). Even between hospitals from unlike regions in the same country, the causes of splenomegaly can vary (18).
The spleen size may be influenced by variation between individuals and past different ethnicities and interfering genetic or infectious factors (Table 1). In Western world countries, the underlying diseases in all historic period groups causing splenomegaly are, in the order of decreasing frequency: hematological diseases, hepatic disease, infections, congestive or inflammatory diseases, and metabolic storage diseases (17, 18). In pediatric patients within the group of hematological disorders, the nigh mutual diagnoses associated with splenomegaly at diagnosis are acute leukemia, lymphoma, hemolytic anemia, chronic myeloid leukemia, and juvenile myelomonocytic leukemia.
Table 1. Causes of splenomegaly to be considered in individuals with different ethnicities due to interfering genetic or infectious factors (19).
Normal Range of the Spleen Size
An increase in the size of the spleen can be demonstrated by clinical examination (palpable spleen exceeding the left costal margin past more than than ii cm) and/or imaging procedures. Its median size corresponds approximately to an individual's fist (in adults 10–12 × 7–viii × three–iv cm, weight 150–200 g, for children meet Table 2). The longest craniocaudal bore can easily exist adamant quantitatively by ultrasound. As a dominion of pollex, from the historic period of toddlers onwards until puberty the formula
is an applicable approach (20). Notwithstanding, as a word of caution, the spleen is palpable in v–10% of all good for you children and in ~30% of all healthy neonates.
Table two. Historic period dependent variation of spleen size parameters (volume, diameters, ratio of longitudinal spleen diameter to xiphod-pubic distance) as determined by ultrasound evaluation in Northward = 317 healthy children and adolescents with normal body weight and summit (three–97% percentile) of both sexes and of Caucasian origin [For details see (3)].
Splenomegaly decreases in frequency with age because the ratio of the splenic volume to the abdominal volume declines over fourth dimension (3). Most importantly, for establishing a right diagnosis of splenomegaly, it is mandatory to have historic period- and body proportion-dependent normal values for the pediatric population from the corresponding geographic area (21–27). Assessment of splenic size should exist done past ultrasound which has emerged during the final decades as the reliable method of choice and tin exist performed easily (3, 15, 28).
Physiological Changes in Spleen Size
The spleen can contain ~8% of the full trunk erythrocytes which are densely packed, resulting in a high organ hematocrit effectually eighty% (29). Changes in spleen size reflect reduced or increased adrenergic activity (thirty). At residual, when the oxygen transport capacity exceeds the body needs, the spleen exhibits a low-hematocrit, low-viscosity state, while during maximal exercise or apneic diving (stressed oxygen transport chapters) the spleen may decrease its volume past ~40%. Contraction seems to be an agile response, mediated past blastoff-adrenergic fibers in the splenic nerve (31), simply too a passive collapse secondary to reduced blood flow (loftier hematocrit stage) has been discussed (32). During maximal exercise or apneic diving up to fifty% of the blood stored in the spleen is transferred to the active circulation (33, 34). However, with regard to the relatively small size of the spleen in humans, the increase in the circulating total claret book is <2% and the increment of hematocrit <10% (31). Thus, any issue upon physical performance is likely to be small.
During pregnancy, cardiovascular and hemodynamic changes occur, every bit the blood volume of the childbearing woman increases gradually over the ix months of gestation, reaching a 40% increase by term (35). Closely related to this increment of plasma volume, the spleen increases in size by l% following the equation: (36) spleen area [cm2] / BMI [kg/yard2] = 1.598 + (0.032 × gestational historic period [weeks]).
Pathological Enlargement of the Spleen Size
As at that place are multiple potential causes of splenomegaly, a conscientious and thorough evaluation is required and it may pose a challenge to notice the underlying crusade (eight, 37). Situations of astute blood loss, therapeutic reduction of the hematocrit in relation to plasma volume (hemodilution), and infections all consequence in physiological transient enlargement of the spleen which is completely reversible subsequently disappearance of the causing trigger (38). The underlying process tin can be classified co-ordinate on the etiology and grouped into six major mechanisms:
i) infectious agents,
ii) hematologic disorders,
iii) infiltrative diseases,
iv) hyperplasia of the white pulp,
5) congestion, and
half-dozen) immunologically mediated diseases.
These mechanisms volition cause full general splenomegaly. In addition, focal lesions (abscesses, cysts -either built or post-traumatic pseudocyst-, hemangioma, main lymphoma in rare cases, metastasis) will not generally event in an overall increase of the size of the organ. Yet, focal lesions can be identified hands by ultrasound examination as typically only defined areas are of the organ are involved.
Hypersplenism (synonym: hypersplenic syndrome) must be distinguished from splenomegaly. (39) Information technology is divers by a meaning reduction in i or more than blood cell types (erythrocytes, leukocytes, thrombocytes) in conjunction with splenomegaly and a compensatory increase of the corresponding precursor cells in the bone marrow. The main divergence is that hypersplenism is a functional abnormality of the spleen while splenomegaly is a structural abnormality. Hypersplenism is a common manifestation in patients with portal hypertension (twoscore). In addition, it is associated with chronic intravascular hemolysis, which may atomic number 82 to platelet activation and thrombosis (run across below).
(i) Infections
The spleen is the largest organ of the lymphatic tissue and the single lymphatic organ which is directly interposed into the blood circulation. During acute or chronic infections including viruses, bacteria, fungi, and mycobacteria (Tabular array 3), the spleen performs enhanced work in antigen clearing and antibody production. This chore is achieved by augmentation of the reticulo-endothelial prison cell number contained within the spleen and thus, these increase in allowed functions may be accompanied by splenomegaly.
Table 3. Pathogenic mechanisms promoting splenomegaly in defined diseases and helpful further investigations to define the diagnosis.
In young adolescence, acute infection with EBV (mononucleosis, "student kissing disease") is a very common cause of splenomegaly which ordinarily is associated with a sore throat, fever and lymphadenopathy. Rare cases with resulting splenic rupture after a minimal trauma take been observed (41, 42).
Splenomegaly is oftentimes an impressive characteristic of malarial infection. While this parasitic infection is rarely observed in Western world countries, information technology represents a very mutual cause of splenomegaly worldwide. Repetitive bouts of malaria induce an abnormal immune response resulting in massive hyperreactive malarial splenomegaly (43). In addition, a large biomass of red cells infected with viable young and mature parasites accumulates in the spleen in asymptomatic persons chronically infected with malaria (44).
In AIDS, the spleen is unremarkably enlarged due to chronic viremia or opportunistic infections (45). Chronic I.5. drug corruption coincides with balmy splenomegaly probably because on the basis of chronic, low-level sepsis from infections.
In the field of hematopoietic stem jail cell transplantation mobilization of stalk cells from a healthy donors's os marrow into the blood stream is achieved past a 5 mean solar day-long administration of granulocyte colony stimulating factor (G-CSF). This scenario mimics bacterial sepsis equally the serum levels of Chiliad-CSF reach a similar altitude. This treatment has besides been reported to exist associated with transient mild enlargement of the spleen (median increase in length eleven mm, range, 0–28 mm) in healthy adult donors (46). Data for children so far are missing.
(ii) Benign hematologic diseases
Immune-mediated devastation of erythrocytes (47), leukocytes, or platelets resulting in cytopenias (autoimmune hemolytic anemia, immune-mediated neutropenia, Felty syndrome, secondary immune thrombocytopenia but non in astute/primary immune thrombocytopenic purpura) may atomic number 82 to splenomegaly. (48–50) Complete blood counts and careful microscopic examination of a blood smear are the commencement diagnostic steps which are followed past hemoglobin electrophoresis if thalassemia or sickle cell anemia are suspected. Amid the hemolytic anemias non caused past defects of the hemoglobin synthesis membrane disorders like spherocytosis or elliptocytosis are the almost common disorders which can be diagnosed non-specific past an acid lysis test or more specific in specialized laboratories for spherocytosis by eosin-5'-maleimide (EMA) fluorescent staining cytometry and for elliptocytosis past osmotic gradient ektacytometry (51–55).
Splenic sequestration crisis in pediatric sickle cell affliction and in chemical compound Hemoglobin S-beta-thalassemia plays a special role every bit up to 30% of these children may develop this life-threatening illness with a mortality rate of up to 15% (56). It is promoted by venous splenic vaso-occlusion by which a large proportion of the total blood book becomes trapped within the spleen. This can result in a severe, rapid driblet in the hemoglobin level leading to hypovolemic shock and possible death (57). The cascade of pathogenic events resulting in splenic sequestration crunch is still a thing of argue. Probably infectious conditions may promote sickle cell formation in the splenic red pulp. Reduced blood flow in parts of the cord, close to or within a draining vein is associated with a local subtract in oxygen concentration and volition increment the formation of sickle cells. This scenario may be transient and reversible or result in all-encompassing irreversible infarction. Consecutive multiple splenic infarcts will cause splenic fibrosis and scarring (58). Over time, this volition lead in pediatric patients with sickle prison cell disease or compound Hb-South-beta-thalassemia to a small, auto infarcted spleen typically diagnosed in adolescent patients. Splenic sequestration crisis is rarely seen in adults because it just tin can occur in a operation spleen. However, if splenic part is maintained, also late adolescent or adult patients may develop this type of crisis.
(three) Infiltrative diseases
Neoplastic cells mainly comprising hematologic malignancies (Hodgkin- and Non-Hodgkin lymphoma, acute and chronic leukemias, myeloproliferative disorders) more than or less regularly infiltrate the spleen causing splenomegaly (59). These diseases should particularly be considered if constitutional symptoms and weight loss is complained. Asymptomatic splenomegaly may be the but physical finding in chronic myeloid leukemia in 1 third of pediatric patients (lx). Abnormal peripheral blood smear and bone marrow examination or lymph node biopsy support key findings when making the diagnosis of malignant cell infiltration.
In case of bone marrow malfunction (east.thou., fibrosis, infiltration by malignant cells) the spleen may resume in the postnatal life its embryonic part in blood prison cell formation. Beyond the fetal life this process termed extramedullary hematopoiesis must e'er be judged upon every bit a pathological finding. It causes the organ to increase in size substantially and may become extreme in myeloproliferative disorders (chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, osteomyelofibrosis) or hematologic disorders (osteopetrosis, thalassemia) occurring at a very low incidence in the pediatric population (61). As pathological mechanisms, likewise proliferation of hematopoietic cells per se as well the sinusoids go occluded thus causing splenomegaly by claret afflux.
Among all infiltrative disorders causing splenomegaly glycogen storage diseases are observed rarely (62). If other more common causes are ruled out, this entity equally listed in Table iii should be considered in patients exhibiting clinical features consistent with inborn errors of metabolic storage diseases (63). Splenomegaly may present as the only symptom in some children and the identification of specific metabolites present in the urine and/or blood, or the reduced activity of specific enzymes in leukocytes volition ostend a suspected diagnosis from this group of inherited diseases.
(iv) Hyperplasia of the white pulp
Activation and hyperplasia of the monocyte/macrophage system in the spleen is likewise known to play a causative role in splenomegaly. Sarcoidosis is a systemic inflammatory disease involving abnormal collections of inflammatory cells that form lumps in afflicted organs termed granulomas. The granulomas comprise tightly packed cell clusters with a key core of macrophages, epithelioid histiocytes, multinucleated behemothic cells, and unknown sarcoid antigens surrounded by a lymphocyte collar. Microscopic involvement of the spleen is present in ~75% of cases, just imaging procedures (CT, ultrasound, MRI) unravel innumerable pocket-size hypodense nodules only in almost 5–10% of cases (64). Pediatric patients aged eight to 15 years-sometime exhibit almost universal lung involvement, with mild splenomegaly. Boosted organs like the eye, the skin, and the liver are involved in thirty–40% of cases (65, 66). Children anile v years and younger merely rarely exhibit splenic infiltration but typically prove a triad of uveitis, arthropathy, and skin rash.
(5) Congestion
The shut anatomical connection of the portal vein system with the splenic vein results in secondary splenic enlargement in example of blockade of the venous blood stream. Hypertension of the portal vein above normal (1–5 mm Hg) may occur due to increased intrahepatic vascular resistance (67). With a farther increase in portal pressure above 10 mm Hg additional complications ascend from the formation of portosystemic collaterals that can promote esophageal and gastric varices with a high chance of bleeding and mortality.
Liver cirrhosis and schistosomiasis are the leading causes for increased portal vein pressure level worldwide. In addition, and with varying frequency on a given national groundwork, multiple hepatobilary disorders may crusade secondary splenomegaly (viral hepatitis, autoimmune hepatitis, cholangitis, choledocal cyst, biliary atresia, alpha-ane-antitrypsine-deficiency, cystic fibrosis, M. Wilson, primary sclerosing cholangitis, galactosemia, Alagille syndrome, etc.). Abnormal findings during physical examination in conjunction with elevated liver enzymes and abnormal liver imaging are mutual cornerstones when establishing a diagnosis of liver disease. The resulting secondary splenomegaly is characterized histologically by an increased size of the red pulp with consecutive fibrosis and an aggregating of hemosiderin loaded macrophages. Siderotic splenic nodules respective to so-chosen Gamna-Gandy bodies detected past histological examination announced as punctate foci of low T1 and T2 signals in MRI (68, 69).
Thrombosis of the hepatic vein (Budd Chiari syndrome) may occur all of a sudden and thereafter the vein may or may not re-canalize (seventy). In patients with underlying liver diseases associated with increased resistance to portal menses re-canalization is observed less oftentimes. If the hepatic vein does not or only partially re-canalize, collateral veins dilate and become serpiginous. Variably these serpiginous vessels bleed into the left and right portal veins or more than distally into the liver. Additional connections may likewise exist with the pericholecystic veins. As sequela, happening variably within a time frame ranging from equally short as a week to as long as a yr, the normal single duct portal vein is replaced by numerous tortuous venous vessels appearing as clangorous transformation of the portal vein, which is also called portal cavernoma (71). The incidence of hypersplenism in conjunction with splenomegaly in patients with portal hypertension is high.
Congestive splenomegaly is a classic sign of organ congestion in decompensated heart failure. Insufficiency of the right ventricle, the left ventricle, or global heart insufficiency can be distinguished by echocardiography and may manifest every bit astute or chronic disease. The underlying causes are multiple and cannot be discussed in the context of this article. Congestive splenomegaly caused by cardiac insufficiency is usually accompanied by the clinical findings of decreased full general performance, dyspnoea, lung edema, cardiac asthma, and peripheral edema. Patients with splenomegaly due to cardiac insufficiency must be treated past targeting at the underlying crusade (72).
(six) Immunologically mediated diseases
Connective tissue diseases may be associated with splenomegaly. These disorders in almost cases are caused past autoimmune mechanism and include but are not express to rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis, granulomatosis with polyangiitis (GPA, formerly chosen Wegener's disease), polymyositis/dermatomyositis, and mixed connective tissue disease (MCTD).
A diagnosis of rheumatoid arthritis (73) or of juvenile idiopathic arthritis (JIA) which start appears before the age of sixteen years is primarily made clinically and may be associated with splenomegaly. Systemic JIA (also termed However disease) should be considered in pediatric patients with symptoms of arthritis, unexplained rash or prolonged fever -peculiarly if quotidian-, iridocyclitis, generalized adenopathy, or splenomegaly. Macrophage activating syndrome (MAS—overlapping with HLH, see below) may be observed as a complication already at the onset of systemic JIA and in this situation splenomegaly can be found in more than one-half of the patients (74). The triad of rheumatoid arthritis, splenomegaly, and persistent neutropenia is termed Felty's syndrome (FS). Typically, FS is diagnosed at the age of 50–lxx years and patients have had RA for more than than 10 years. FS is observed very rarely in patients with JIA (75).
Systemic lupus erythematosus (SLE) can touch well-nigh whatsoever organ of the body and vascular changes are a hallmark in the pathogenesis. The clinical heterogeneity of systemic SLE and the lack of pathognomonic features or tests pose a diagnostic challenge for the clinician (76). The product of a number of antinuclear antibodies (ANA) are a prominent feature of the disease. Splenomegaly occurs in 9–18% of patients with systemic SLE and is more frequent in younger children (77).
Systemic sclerosis (SSc) is a disorder exhibiting a complex interaction of inflammation, fibrosis and vascular damage. Scleroderma and Raynaud's phenomenon are characteristic early findings. Progressive systemic sclerosis may exist complicated by idiopathic portal hypertension, however, an enhanced resistivity of the splenic avenue may exist associated with systemic SLE. High values of the splenic artery resistivity index (SARI) at doppler ultrasound assessment signal to an intrinsic spleen vascular impairment allowing to separate the cause of splenomegaly from liver fibrosis (78).
Granulomatosis with polyangiitis (GPA, formerly chosen Wegener's disease) is a form of necrotizing vasculitis that is associated with granuloma formation. Nose, lungs, kidneys are primarily affected. Reports of splenic involvements are rare. In some patients with GPA and splenomegaly infarctions of the distal parenchymal splenic arteries accept been observed with either a focal or lengthened pattern (79).
Polymyositis is characterized by inflammation and degeneration of the muscles. When the skin is also affected, it is called dermatomyositis (DMS). Approx. 1 3rd of adult patients with DMS develop cancer and in a considerable proportion (~forty%) the diagnosis of DMS is made later on the diagnosis of a malignancy. The proportion of children with malignancies is smaller but conscientious evaluation to dominion out a malignoma -specially in cases presenting with splenomegaly- should be undertaken at the time when a diagnosis of DMS is established (lxxx).
Mixed connective tissue disease (MCTD), also chosen Sharp syndrome, is a rare autoimmune disorder. MCTD is characterized past findings unremarkably observed in the post-obit three dissimilar connective tissue disorders: systemic lupus erythematosus, scleroderma, and polymyositis. Some patients affected may also show symptoms of rheumatoid arthritis. MCTD commonly affects women under the age of 30 years. Splenomegaly tin exist observed as described above in cases exhibiting the 3 disorders.
Familial Mediterranean fever (FMF) is a hereditary auto-inflammatory disorder caused by mutations in the Mediterranean fever factor, which encodes the pyrin protein (81). Information technology is characterized past periodic episodes of fever and serosal inflammation, mostly lasting 1–3 days and spontaneous remission. At preschool age, fever may be the single symptom during a febrile attack but in more than than 90% of patients also abdominal pain affects the whole abdomen with all signs of peritonitis. Gross amounts of serum amyloid A protein (SAA) are produced during attacks, and at a lower rate in between (82). Amyloid A accumulates mainly in the kidney, every bit well as the heart, spleen, thyroid and gastrointestinal tract. Mild splenomegaly is a finding in younger adults (83). In one one-half of the children with FMF splenomegaly is detectable past ultrasound (84). The increase in size of the spleen seems to be higher during attacks compared to attack-gratis periods (85). In beast models, macrophages located in the vicinity of splenic amyloid deposits are considered to play a role in amyloid degradation (86).
Autoimmune lymphoproliferative syndrome (ALPS) is a rare lymphoproliferative disorder, normally presenting in pediatric patients with splenomegaly, massive lymphadenopathy, and in the course of the disease with an increased incidence of lymphoma. It represents a genetically dysregulated allowed condition of abnormally prolonged lymphocyte survival caused by defective Fas mediated apoptosis (87). Double negative T-cells (TCRαβ+ CD4− CD8− T cells) are a feature finding in ALPS. During periods of disease action these cells infiltrate and disorganize the splenic marginal zone and cause abnormal marginal zone B-jail cell function (88). Most patients will require treatment with immunosuppressive drugs that will effectively reduce or meliorate symptoms (89).
Hemophagocytic lymphohistiocytosis (HLH) is a rare simply severe form of immune dysregulation. The disorder presents as unremitting fever, cytopenia, hepatosplenomegaly, coagulopathy, and superlative of typical HLH biomarkers among these ferritin, IL2-R, serum triglycerides, claret cytopenia, elevated aminotransferase (ninety). Cytohistological examination of lymphoid tissue, os marrow and spleen show accumulation of lymphocytes and macrophages, sometimes with hemophagocytic activeness (91). HLH may cause a life-threatening state of hyperactivated immune response that is observed in the setting of genetic mutations (familial HLH) as well as infectious, inflammatory, or neoplastic triggers (92). Familial HLH is treated with chemotherapy for bridging the fourth dimension until hematopoietic stem cell transplantation tin be performed. HLH occurring in the context of rheumatic diseases (macrophage activation syndrome) is treated with glucocorticoids, IL-1 blockade, or cyclosporine A. In other forms of HLH, addressing the underlying trigger is essential.
The frequency of occurrence of histiocytic diseases peaks in childhood and boyhood. Disorders belonging to this entity are generally rare and their variable clinical course and variable morphology contribute to the diagnostic challenge. Histiocytoses are subdivided into Langerhans cell histiocytosis (LCH) and the then-chosen non-LCH, such as juvenile xanthogranuloma, Erdheim-Chester disease and Rosai-Dorfman affliction (93). In babyhood the near common forms of histiocytosis comprise LCH (also called histiocytosis Ten) and juvenile xanthogranuloma. LCH primarily affects children from birth to age xv years (94). The disease exhibits features of both an abnormal reactive and a neoplastic procedure with an abnormal increase in proliferating dendritic histiocyte cells. These cells may infiltrate a single organ whereas disseminated LCH may involve multiple organs like os marrow, lungs, liver, spleen, lymph nodes, gastrointestinal tract, and the pituitary gland. Based on the extent of organ involvement at diagnosis, namely, single-system LCH, and multisystem LCH with unifocal or multifocal organ interest must be distinguished. Organs may be afflicted by infiltration only or / and by resulting dysfunction (95). Diagnosis requires a biopsy and histiocytes in LCH are CD1a+ while BRAFv600E mutations have been institute in 50–55% of cases. The survival rates for patients without organ dysfunction are fantabulous, still, mortality rates for patients with organ dysfunction may accomplish 20% (96). Splenomegaly in patients with LCH usually is part of a multifocal systemic affliction, whereas isolated splenic LCH is extremely rare.
Last Remarks
The spleen combines in one organ an efficient phagocytosis of senescent ruby cells in conjunction with the recycling of iron, the cognition, capture and elimination of pathogens, and the induction of adaptive immune responses. The separation into different splenic compartments promotes tasks that are not fulfilled in other lymphoid organs.
Splenomegaly in most cases is the result of a systemic illness. The underlying pathophysiological machinery can be subdivided into infectious, hematologic, infiltrative, vascular, and immunological diseases with resulting abnormalities of the lymphoid, reticuloendothelial, or vascular components of the spleen. A precise cess of spleen dimensions is easily and reliably achievable by ultrasound examination. The interpretation of the data must be based on age-dependent normal values in pediatric patients.
The list of possibilities included in the differential diagnosis of splenomegaly in children and adolescents is extensive. Thus, the assessment of an enlarged spleen hinges on a comprehensive analysis of clinical data. Essential is the correct nomenclature of the associated findings particularly of the full claret count, and the status of the liver and lymph nodes (Figure 3). In a given patient the clinician must advisedly balance all possible differential diagnoses, the individual clinical features and the results of laboratory and imaging investigations.
Effigy 3. Algorithms for a non-evidence based diagnostic approach toward a pediatric or adolescent patient presenting with splenomegaly on physical examination. Diagnostic steps are grouped into 1st line, 2nd line, and tertiary line approaches. The extensive list of differential diagnoses excludes more detailed data in this flow nautical chart for which the reader is kindly referred to the text and to Table iii of this review. ALPS, autoimmune lymphoproliferative syndrome; CRP C, reactive protein; EMA, eosin-5'-maleimide; FMF, familial Mediterranean fever; Hb, hemoglobin; HLH, hemophagocytic lymphohistiocytosis; juv., juvenile; LDH, lactate dehydrogenase; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; SLE, systemic lupus erythematosus; SSc, systemic sclerosis.
Infection is the most common cause of an enlarged spleen in children, but after treating an infection successfully the size of the spleen must be re-evaluated and persisting splenomegaly should always exist taken seriously. The private clinical picture show guides the urgency of diagnostic procedures. Beyond acute viral illness, constitutional symptoms such as fever, weight loss or dark sweats are symptoms suggesting a illness nowadays in other organs or systems. But also isolated splenomegaly can exist associated with malignancy.
So far at that place is no established bear witness-based management strategy for a pediatric patient with splenomegaly, nonetheless, essential investigations must exclude lymphadenopathy, pathological findings of the liver, gut, and breast (Figure 3) (97). In selected patients with simply mild splenomegaly information technology may be appropriate to monitor the course for some weeks. However, if the size of the spleen enlarges and/or new symptoms or clinical signs arise, then the patient should be reassessed and establishing a diagnosis becomes mandatory.
Author Contributions
MS and CC adult the concept of this review, wrote the start draft of the typoscript, critically discussed the content, and approved the concluding version of the typoscript.
Funding
Publication costs were funded past the Sächsische Landesuniversitätsbibliothek (SLUB).
Conflict of Involvement
The authors declare that the inquiry was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Poulin EC, Mamazza J. Laparoscopic splenectomy: lessons from the learning curve. Tin can J Surg. (1998) 41:28–36.
PubMed Abstruse | Google Scholar
3. Pelizzo Thou, Guazzotti M, Klersy C, Nakib G, Costanzo F, Andreatta E, et al. Spleen size evaluation in children: time to define splenomegaly for pediatric surgeons and pediatricians. PLoS One. (2018) thirteen:e0202741. doi: 10.1371/journal.pone.0202741
PubMed Abstruse | CrossRef Full Text | Google Scholar
5. Puranik AK, Mehra R, Chauhan S, Pandey R. Wandering spleen: a surgical enigma. Gastroenterol Rep. (2017) 5:241–3.
Google Scholar
eight. Chapman J, Bansal P, Goyal A, Azevedo AM. Splenomegaly. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2021).
Google Scholar
nine. Buyssens N, Paulus G, Conservative N. Ellipsoids in the human spleen. Virchows Curvation A Pathol Anat Histopathol. (1984) 403:27–40. doi: 10.1007/BF00689336
CrossRef Total Text | Google Scholar
10. Steiniger BS, Seiler A, Lampp Grand, Wilhelmi V, Stachniss V. B lymphocyte compartments in the human splenic red pulp: capillary sheaths and periarteriolar regions. Histochem Cell Biol. (2014) 141:507–18. doi: 10.1007/s00418-013-1172-z
PubMed Abstract | CrossRef Full Text | Google Scholar
xi. Steiniger BS, Pfeffer H, Guthe M, Lobachev O. Exploring human splenic red pulp vasculature in virtual reality: details of sheathed capillaries and the open capillary network. Histochem Cell Biol. (2021) 155:341–54. doi: 10.1007/s00418-020-01924-3
PubMed Abstract | CrossRef Full Text | Google Scholar
xiv. O'Reilly RA. Splenomegaly in 2505 patients at a big University medical centre from 1913 to 1995. 1963 to 1995:449 patients. West J Med. (1998) 169:88–97.
Google Scholar
15. Ohmae H, Kawamoto F, Ishii A, Leafasia J, Kere N. Detecting splenomegaly by ultrasound. Lancet. (1991) 338:826–7. doi: 10.1016/0140-6736(91)90720-A
CrossRef Full Text | Google Scholar
16. Lowenthal MN, Hutt MSR, Jones IG, Mohelsky V, O'Riordan EC. Massive splenomegaly in Northern Zambia. I. analysis of 344 cases. Trans Royal Soc Trop Med Hyg. (1980) 74:91–viii. doi: 10.1016/0035-9203(lxxx)90019-Ten
PubMed Abstruse | CrossRef Full Text | Google Scholar
nineteen. Weinreb NJ, Rosenbloom Be, Splenomegaly hypersplenism and hereditary disorders with splenomegaly. Open up J Genet. (2013) 3:2. doi: 10.4236/ojgen.2013.31004
CrossRef Full Text | Google Scholar
xx. Allan R, Downey P, Kate Paddick K, Cheung G. Normal sonographic measurements and guidelines for EIF, CPC, fetal renal dilatation, markers for chromosomal abnormalities, and fetal abnormalities. Revised Version, Nov 2014, Page iv Sectionalization of Medical Imaging, Flinders Medical Centre, S Australia http://www.users.on.net/~cardal/Normal_Sonographic_Measurements__and_markers_guidelines_Nov_2014_final.pdf Assessed April 2021
Google Scholar
21. Megremis S, Alegakis A, Koropouli M. Ultrasonographic spleen dimensions in preterm infants during the first three months of life. J Ultrasound Med. (2007) 26:329–35. doi: 10.7863/jum.2007.26.3.329
PubMed Abstract | CrossRef Full Text | Google Scholar
22. Ezeofor SN, Obikili EN, Anyanwu GE, Onuh AC, Mgbor SO. Sonographic assessment of the normal limits of the spleen in healthy school children in South-East Nigeria. Niger J Clin Pract. (2014) 17:484–8. doi: ten.4103/1119-3077.134046
PubMed Abstract | CrossRef Full Text | Google Scholar
23. Chow KU, Luxembourg B, Seifried E, Bonig H. Spleen size is significantly influenced by body height and sex: establishment of normal values for spleen size at US with a cohort of 1200 healthy individuals. Radiology. (2016) 279:306–thirteen. doi: 10.1148/radiol.2015150887
PubMed Abstract | CrossRef Full Text | Google Scholar
24. Kebede T, Admassie D. Spleen length in childhood with ultrasound normal based on age at Tikur Anbessa Hospital. Ethiop Med J. (2009) 47:49–53.
PubMed Abstruse | Google Scholar
25. Eze CU, Agwu KK, Ezeasor DN, Ochie Grand, Aronu AE, Agwuna KK, et al. Sonographic biometry of spleen among school historic period children in Nsukka, Southeast, Nigeria. Afr Health Sci. (2013) 13:384–92. doi: 10.4314/ahs.v13i2.27
PubMed Abstract | CrossRef Full Text | Google Scholar
26. Eze CU, Agwu KK, Ezeasor DN, Agwuna KK, Aronu AE. Sonographic determination of spleen to left kidney ratio among Igbo school age children of south east Nigeria. Afr Health Sci. (2014) fourteen:246–54. doi: 10.4314/ahs.v14i1.38
PubMed Abstract | CrossRef Full Text | Google Scholar
27. Al-Imam O, Suleiman A, Khuleifat South. Ultrasound assessment of normal splenic length and spleen-to kidney ratio in children. East Meditter Health J. (2000) half dozen:514–6.
PubMed Abstract | Google Scholar
29. Koga T. Correlation between exclusive area of the spleen by ultrasonic tomography and bodily volume of the removed spleen. J Clin Ultrasound. (1979) 7:119–twenty. doi: x.1002/jcu.1870070208
PubMed Abstract | CrossRef Full Text | Google Scholar
30. Stewart IB, McKenzie DC. The human spleen during physiological stress. Sports Med. (2002) 32:361–9. doi: 10.2165/00007256-200232060-00002
CrossRef Full Text | Google Scholar
31. Shephard RJ. Responses of the human spleen to exercise. J Sports Sci. (2016) 34:929–36. doi: 10.1080/02640414.2015.1078488
CrossRef Full Text | Google Scholar
32. Allsop P, Peters AM, Stuttle AWJ, Deenmamode M, Gwilliam ME, Myers MJ. Intrasplenic blood cell kinetics in man before and after brief maximal exercise. Clin Sci. (1992) 83:47–54. doi: 10.1042/cs0830047
PubMed Abstract | CrossRef Full Text | Google Scholar
33. Froelich JW, Strauss HW, Moore RH, McKusick KA. Redistribution of visceral blood volume in upright exercise in good for you volunteers. J Nucl Med. (1988) 29:1714–8.
PubMed Abstruse | Google Scholar
34. Schagatay E, Andersson JP, Hallen Thou, Palsson B. Selected contribution: role of spleen emptying in prolonging apneas in humans. J Appl Physiol. (2001) ninety:1623–9. doi: x.1152/jappl.2001.90.iv.1623
PubMed Abstract | CrossRef Total Text | Google Scholar
35. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. (2000) 24:11–4. doi: ten.1016/S0146-0005(00)80047-6
CrossRef Total Text | Google Scholar
36. Maymon R, Strauss S, Vaknin Z, Weinraub Z, Herman A, Gayer G. Normal sonographic values of maternal spleen size throughout pregnancy. Ultrasound Med Biol. (2006) 32:1827–31. doi: ten.1016/j.ultrasmedbio.2006.06.017
PubMed Abstract | CrossRef Full Text | Google Scholar
37. Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and direction. Blood Rev. (2009) 23:105–xi. doi: 10.1016/j.blre.2008.10.001
CrossRef Full Text | Google Scholar
38. McKenzie CV, Colonne CK, Yeo JH, Fraser ST. Splenomegaly: pathophysiological bases and therapeutic options. Int J Biochem Cell Biol. (2018) 94:40–3. doi: 10.1016/j.biocel.2017.11.011
PubMed Abstract | CrossRef Total Text | Google Scholar
39. Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, et al. Hypersplenism: history and electric current status. Exp Ther Med. (2016) 12:2377–82. doi: 10.3892/etm.2016.3683
CrossRef Full Text | Google Scholar
40. Li 50, Duan Yard, Chen W, Jiang A, Li X, Yang J, et al. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med. (2017) 15:111. doi: 10.1186/s12967-017-1214-8
PubMed Abstract | CrossRef Full Text | Google Scholar
41. Rinderknecht Equally, Pomerantz WJ. Spontaneous splenic rupture in infectious mononucleosis: case report and review of the literature. Pediatr Emerg Intendance. (2012) 28:1377–9. doi: 10.1097/PEC.0b013e318276c78a
PubMed Abstract | CrossRef Full Text | Google Scholar
42. Sylvester JE, Buchanan BK, Paradise SL, Yauger JJ, Beutler AI. Association of splenic rupture and infectious mononucleosis: a retrospective analysis and review of return-to-play recommendations. Sports Health. (2019) 11:543–9. doi: 10.1177/1941738119873665
PubMed Abstract | CrossRef Full Text | Google Scholar
43. Bisoffi Z, Leoni S, Angheben A, Beltrame A, Eseme Iron, Gobbi F, et al. Chronic malaria and hyper-reactive malarial splenomegaly: a retrospective study on the largest series observed in a non-endemic country. Malar J. (2016) 5:230. doi: 10.1186/s12936-016-1274-x
PubMed Abstract | CrossRef Total Text | Google Scholar
44. Kho Southward, Qotrunnada L, Leonardo L, Andries B, Wardani PAI, Fricot A, et al. Hidden biomass of intact malaria parasites in the human spleen. Due north Engl J Med. (2021) 384:2067–nine. doi: 10.1056/NEJMc2023884
PubMed Abstract | CrossRef Full Text | Google Scholar
46. Platzbecker U, Prange-Krex G, Bornhauser G, Koch R, Soucek S, Aikele P, et al. Spleen enlargement in healthy donors during Thou-CSF mobilization of PBPCs. Transfusion. (2001) 41:184–9. doi: 10.1046/j.1537-2995.2001.41020184.10
PubMed Abstract | CrossRef Full Text | Google Scholar
48. Kim TO, Despotovic JM. Primary and secondary immune cytopenias: evaluation and handling approach in children. Hematol Oncol Clin N Am. (2019) 33:489–506. doi: 10.1016/j.hoc.2019.01.005
PubMed Abstract | CrossRef Full Text | Google Scholar
49. Saettini F, Cattoni A, Redaelli Thou, Silvestri D, Ferrari GM, Biondi A, et al. Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in babyhood allowed thrombocytopenia. Acta Paediatr. (2021) 110:643–51. doi: 10.1111/apa.15593
PubMed Abstract | CrossRef Full Text | Google Scholar
50. Despotovic JM, Grimes AB. Pediatric ITP: is it different from adult ITP? hematology. Am Soc Hematol Educ Program. (2018) 2018:405–11. doi: ten.1182/asheducation-2018.1.405
CrossRef Full Text | Google Scholar
53. Bianchi P, Fermo E, Vercellati C, Marcello AP, Porretti Fifty, Cortelezzi A, et al. Diagnostic ability of laboratory tests for hereditary spherocytosis: a comparing written report in 150 patients grouped according to molecular and clinical characteristics. Haematologica. (2012) 97:516–23. doi: 10.3324/haematol.2011.052845
PubMed Abstruse | CrossRef Full Text | Google Scholar
54. Kar R, Mishra P, Pati HP. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol. (2010) 32(1 Pt 2):viii–16. doi: 10.1111/j.1751-553X.2008.01098.x
PubMed Abstruse | CrossRef Full Text | Google Scholar
55. Lazarova Eastward, Gulbis B, Oirschot BV, van Wijk R. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience. Clin Chem Lab Med. (2017) 55:394–402. doi: 10.1515/cclm-2016-0290
PubMed Abstruse | CrossRef Full Text | Google Scholar
56. Kane I, Nagalli S. Splenic sequestration crunch. In: StatPearls. Treasure Island, FL: StatPearls Publishing (2020).
Google Scholar
58. Ladu AI, Aiyenigba AO, Adekile A, Bates I. The spectrum of splenic complications in patients with sickle prison cell affliction in Africa: a systematic review. Br J Haematol. (2021) 193:26–42. doi: x.1111/bjh.17179
PubMed Abstract | CrossRef Total Text | Google Scholar
threescore. Suttorp Thousand, Schulze P, Glauche I, Göhring G, von Neuhoff N, Metzler M, et al. Front end-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia. (2018) 32:1657–69. doi: 10.1038/s41375-018-0179-nine
PubMed Abstruse | CrossRef Full Text | Google Scholar
61. Suttorp G, Millot F, Sembill S, Deutsch H, Metzler Chiliad. Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia. Cancers. (2021) 13:798. doi: 10.3390/cancers13040798
PubMed Abstract | CrossRef Full Text | Google Scholar
62. Anderson S. Newborn screening for lysosomal storage disorders. J Pediatr Health Intendance. (2018) 32:285–94. doi: 10.1016/j.pedhc.2017.04.016
CrossRef Full Text | Google Scholar
66. Fausto N, Abbas A. Robbins and Cotran Pathologic Basis of Disease, 7th Edn. Philadelphia, PA: Elsevier/Saunders (2004). p. 737–9.
Google Scholar
67. Giouleme O, Theocharidou Due east. Management of portal hypertension in children with portal vein thrombosis. J Pediatr Gastroenterol Nutr. (2013) 57:419–25. doi: 10.1097/MPG.0b013e3182a1cd7f
PubMed Abstract | CrossRef Full Text | Google Scholar
69. Zhang J, Tao R, You Z, Dai Y, Fan Y, Cui J, et al. Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices. PLoS ONE. (2013) eight:e55626. doi: ten.1371/journal.pone.0055626
PubMed Abstract | CrossRef Full Text | Google Scholar
seventy. Kathuria R, Srivastava A, Yachha SK, Poddar U, Baijal SS. Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome. Eur J Gastroenterol Hepatol. (2014) 26:1030–eight. doi: 10.1097/Meg.0000000000000144
PubMed Abstract | CrossRef Full Text | Google Scholar
73. Fishman D, Isenberg DA. Splenic involvement in rheumatic diseases. Semin Arthritis Rheum. (1997) 27:141–55. doi: ten.1016/S0049-0172(97)80013-three
CrossRef Total Text | Google Scholar
74. Minoia F, Davì Due south, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter written report of 362 patients. Arthritis Rheumatol. (2014) 66:3160–nine. doi: 10.1002/fine art.38802
PubMed Abstract | CrossRef Total Text | Google Scholar
75. Owlia MB, Newman Thou, Akhtari M. Felty's syndrome, insights and updates. Open Rheumatol J. (2014) eight:129–36. doi: x.2174/1874312901408010129
CrossRef Full Text | Google Scholar
76. Ma M, Hui-Yuen JS, Cerise JE, Iqbal Due south, Eberhard BA. Validation of the 2019 European league against Rheumatism/American higher of rheumatology criteria compared to the 1997 American College of Rheumatology Criteria and the 2012 Systemic Lupus International Collaborating Clinics Criteria in Pediatric Systemic Lupus Erythematosus. Arthritis Care Res. (2020) 72:1597–601. doi: x.1002/acr.24057
PubMed Abstruse | CrossRef Full Text | Google Scholar
77. Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, et al. Features of 847 childhood-onset systemic lupus erythematosus patients in three age groups at diagnosis: a brazilian multicenter study. Arthritis Care Res. (2016) 68:1736–41. doi: x.1002/acr.22881
PubMed Abstract | CrossRef Full Text | Google Scholar
78. Tarantino Thousand, Spanò A, Loi G, Parisi A, Tarantino M, Brancaccio Thousand, et al. Is spleen circulation impaired in systemic sclerosis and what is the part of liver fibrosis? Earth J Gastroenterol. (2011) 17:1606–13. doi: ten.3748/wjg.v17.i12.1606
PubMed Abstruse | CrossRef Full Text | Google Scholar
79. Martusewicz-Boros M, Baranska I, Wiatr Due east, Bestry I, Roszkowski-Sliz K. Asymptomatic appearance of splenic infarction in Wegener'southward granulomatosis. Pol J Radiol. (2011) 76:43–5.
PubMed Abstruse | Google Scholar
83. Ornek A, Kurucay One thousand, Henning BF, Pagonas N, Schlottmann R, Schmidt Nosotros, et al. Sonographic assessment of spleen size in Turkish migrants with Familial Mediterranean fever in Frg. J Ultrasound Med. (2014) 33:1991–seven. doi: ten.7863/ultra.33.eleven.1991
PubMed Abstract | CrossRef Full Text | Google Scholar
84. Marzouk H, Lotfy HM, Farag Y, Rashed LA, El-Garf K. Mean platelet volume and splenomegaly equally useful markers of subclinical activity in egyptian children with familial mediterranean fever: a cross-sectional study. Int J Chronic Dis. (2015) 2015:152616. doi: ten.1155/2015/152616
PubMed Abstract | CrossRef Full Text | Google Scholar
85. Aharoni D, Hiller North, Hadas-Halpern I. Familial Mediterranean fever: abdominal imaging findings in 139 patients and review of the literature. Abdominal Imaging. (2000) 25:297–300. doi: 10.1007/s002610000006
PubMed Abstract | CrossRef Total Text | Google Scholar
86. Lundmark One thousand, Vahdat Shariatpanahi A, Westermark GT. Depletion of spleen macrophages delays AA amyloid development: a report performed in the rapid mouse model of AA amyloidosis. PLoS I. (2013) viii:e79104. doi: x.1371/journal.pone.0079104
PubMed Abstruse | CrossRef Full Text | Google Scholar
87. Matson DR, Yang DT. Autoimmune lymphoproliferative syndrome: an overview. Curvation Pathol Lab Med. (2020) 144:245–51. doi: 10.5858/arpa.2018-0190-RS
CrossRef Full Text | Google Scholar
88. Neven B, Bruneau J, Stolzenberg MC, Meyts I, Magerus-Chatinet A, Moens 50, et al. Lacking anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients. Blood. (2014) 124:1597–609. doi: 10.1182/blood-2014-02-553834
PubMed Abstract | CrossRef Full Text | Google Scholar
91. Favara Exist. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol. (1992) 9:63–74.
Google Scholar
92. Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Claret. (2020) 135:1332–43. doi: ten.1182/claret.2019000936
CrossRef Full Text | Google Scholar
93. Classen CF, Minkov M, Lehrnbecher T. The non-langerhans prison cell histiocytoses (Rare Histiocytoses) - clinical aspects and therapeutic approaches. Klin Padiatr. (2016) 228:294–306. doi: 10.1055/south-0042-109713
PubMed Abstruse | CrossRef Full Text | Google Scholar
94. Tillotson CV, Anjum F, Patel BC. Langerhans prison cell histiocytosis. In: StatPearls. Treasure Isle, FL: StatPearls Publishing (2021).
Google Scholar
97. Odom LF, Tubergen DG. Splenomegaly in Children-Identifying the Crusade Postgraduate Medicine. (1979). p. 191–200. doi: 10.1080/00325481.1979.11715123
CrossRef Total Text | Google Scholar
Source: https://www.frontiersin.org/articles/10.3389/fped.2021.704635/full
0 Response to "Artlabeling Activity Anatomy and Histological Organization of the Spleen"
Post a Comment